Who owns ELIEM THERAPEUTICS INC?
- Ticker: ELYM
- CUSIP Number: 28658r106
Tip: Access positions for across all investors
Analyze quarterly positions in Eliem Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Eliem Therapeutics stock
Who bought or sold ELIEM THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
RA Capital Management | 13M | $36M | 0% | Mar 2024 |
|
BML Capital Management | 2.2M | $6.0M | 1% | Mar 2024 |
|
Vanguard Group | 311k | $851k | 0% | Mar 2024 |
|
Geode Capital Management | 67k | $183k | 0% | Mar 2024 |
|
Bridgeway Capital Management | 55k | $151k | 0% | Mar 2024 |
|
Northern Trust | 44k | $119k | 289% | Mar 2024 |
|
BlackRock | 30k | $83k | -3% | Mar 2024 |
|
Tudor Investment Corporation | 30k | $81k | 0% | Mar 2024 |
|
Millennium Management | 20k | $55k | 9% | Mar 2024 |
|
Chicago Partners Investment | 12k | $45k | 0% | Mar 2024 |
|
Advisor Group Holdings | 8.3k | $22k | 0% | Mar 2024 |
|
UBS Group | 5.9k | $16k | 100% | Mar 2024 |
|
Tower Research Capital | 3.6k | $9.9k | -7% | Mar 2024 |
|
Morgan Stanley | 1.7k | $4.7k | 0% | Mar 2024 |
|
Qube Research & Technologies | 981.00 | $2.7k | 0% | Mar 2024 |
|
Royal Bank of Canada | 63.00 | $0 | 75% | Mar 2024 |
|
Wells Fargo & Company | 50.00 | $137.000000 | 4% | Mar 2024 |
|
Who sold out of Eliem Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
HPM Partners | Dec 2023 | 14k | $37k |